Dr. Hönle AG

EANS-News: Impact of the manroland Insolvency on Hönle

--------------------------------------------------------------------------------
  Corporate news transmitted by euro adhoc. The issuer/originator is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Company Information


Gräfeling/München (euro adhoc) - manroland AG filed a petition to initiate
insolvency proceedings on 25 November 2011. The insolvency proceedings are to
enable speedy restructuring of the company and provide manroland AG with the
opportunity for a successful new start on the basis of improved general
conditions. manroland is the third largest manufacturer of offset printing
machines worldwide and the international market leader in webfed printing
systems. The Management Board of manroland AG filed a request for
self-administration with respect to the restructuring efforts.  

The Dr. Hönle AG Management Board does not rule out the possibility of sustained
successful restructuring of manroland AG. In particular, according to the Dr.
Hönle AG Management Board, there is a good chance that a (strategic) investor
can be found for manroland AG within the scope of the insolvency proceedings.
According to the Dr. Hönle Management Board, the initiated insolvency
proceedings afford the opportunity to step up the necessary restructuring of the
company and, consequently, to return to positive corporate development. 

Dr. Hönle AG will initiate all measures required in the short term in order to
keep the impact of the insolvency of the printing machine manufacturer on Hoenle
Group´s sales and earnings development as low as possible. Currently, the
Management Board assumes that the existing favourable order position with
manroland AG will not be impaired by the insolvency proceedings to any great
extent as manroland AG's business activities shall continue to run as normal.
The current receivables portfolio of the Hoenle Group vis á vis manroland AG
amounts to ca EUR 1.4 million. 

About Hönle:
Dr. Hönle AG is a listed technology company with registered head office in
Gräfelfing, near Munich. With a staff level of ca. 400 employees, the Hönle
Group is one of the world´s leading systems suppliers in the UV technology
segment. The equipment and systems are used for drying inks and coatings, curing
adhesives and plastics, disinfecting surfaces, and in the simulation of natural
sunlight. The Company´s business activities focus also on the development and
sale of industrial adhesives and compounds. The Group is represented by own
companies and sales partners worldwide at 50 locations in more than 20
countries.


Further inquiry note:
Peter Weinert
Tel.: +49 89 85608 173
E-Mail: peter.weinert@hoenle.de
Web: www.hoenle.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


company:     Dr. Hönle AG
             Lochhamer Schlag  1
             D-82166 Gräfeling/München
phone:       +49 89 85608 0
FAX:         +49 89 85608 101
mail:     ir@hoenle.de
WWW:      www.hoenle.de
sector:      Instrument Engineering
ISIN:        DE0005157101
indexes:     CDAX, Prime All Share, Technology All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Hamburg, Stuttgart, Düsseldorf, Hannover, München 
language:   English
 



Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: